148 related articles for article (PubMed ID: 11259613)
21. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
Lok CN; Lang AJ; Mirski SE; Cole SP
Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
[TBL] [Abstract][Full Text] [Related]
22. NF-M trans-activates the human DNA topoisomerase II alpha promoter independently of c-Myb in HL-60 cells.
Brandt TL; Kroll DJ
Leuk Res; 1997 Aug; 21(8):711-20. PubMed ID: 9379678
[TBL] [Abstract][Full Text] [Related]
23. Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblasts with human topoisomerase IIalpha cDNA: selective restoration of the sensitivity to DNA religation inhibitors.
Khélifa T; René B; Le Mée S; Lambert B; Saucier JM; Markovits J; Jacquemin-Sablon H; Jacquemin-Sablon A
Cancer Res; 1999 Oct; 59(19):4927-36. PubMed ID: 10519406
[TBL] [Abstract][Full Text] [Related]
24. Characterization of promoter elements involved in the down-regulation of topoisomerase IIalpha expression in a drug-resistant cell line.
Saxena D; Yiu GK; Ni X; Huang KC; Mantovani R; Jacquemin-Sablon AG; Ng SW
Gene; 2004 Nov; 342(1):145-55. PubMed ID: 15527974
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of human topoisomerase IIalpha expression correlates with relative amounts of specificity factors Sp1 and Sp3 bound at proximal and distal promoter regions.
Williams AO; Isaacs RJ; Stowell KM
BMC Mol Biol; 2007 May; 8():36. PubMed ID: 17511886
[TBL] [Abstract][Full Text] [Related]
26. Nuclear Localization and Gene Expression Modulation by a Fluorescent Sequence-Selective p-Anisyl-benzimidazolecarboxamido Imidazole-Pyrrole Polyamide.
Kiakos K; Pett L; Satam V; Patil P; Hochhauser D; Lee M; Hartley JA
Chem Biol; 2015 Jul; 22(7):862-75. PubMed ID: 26119998
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of ICBP90, a novel CCAAT-binding protein, overcomes cell contact inhibition by forcing topoisomerase II alpha expression.
Hopfner R; Mousli M; Oudet P; Bronner C
Anticancer Res; 2002; 22(6A):3165-70. PubMed ID: 12530060
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional regulation of differentiation, selective toxicity and ATGCAAAT binding of bisbenzimidazole derivatives in human melanoma cells.
Wong SS; Sturm RA; Michel J; Zhang XM; Danoy PA; McGregor K; Jacobs JJ; Kaushal A; Dong Y; Dunn IS
Biochem Pharmacol; 1994 Mar; 47(5):827-37. PubMed ID: 7510966
[TBL] [Abstract][Full Text] [Related]
29. Cloning and characterization of the 5'-flanking sequence for the human DNA topoisomerase II beta gene.
Ng SW; Liu Y; Schnipper LE
Gene; 1997 Dec; 203(2):113-9. PubMed ID: 9426241
[TBL] [Abstract][Full Text] [Related]
30. Induction of resistance to etoposide and adriamycin in a human glioma cell line treated with antisense oligodeoxynucleotide complementary to the messenger ribonucleic acid of deoxyribonucleic acid topoisomerase II alpha.
Kuriyama M; Tsutsui K; Tsutsui K; Ono Y; Tamiya T; Matsumoto K; Furuta T; Ohmoto T
Neurol Med Chir (Tokyo); 1997 Sep; 37(9):655-61; discussion 661-2. PubMed ID: 9330528
[TBL] [Abstract][Full Text] [Related]
31. Binding of f-PIP, a pyrrole- and imidazole-containing triamide, to the inverted CCAAT box-2 of the topoisomerase IIalpha promoter and modulation of gene expression in cells.
Le NM; Sielaff AM; Cooper AJ; Mackay H; Brown T; Kotecha M; O'Hare C; Hochhauser D; Lee M; Hartley JA
Bioorg Med Chem Lett; 2006 Dec; 16(24):6161-4. PubMed ID: 17011187
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of DNA binding of the NF-Y transcription factor by the pyrrolobenzodiazepine-polyamide conjugate GWL-78.
Kotecha M; Kluza J; Wells G; O'Hare CC; Forni C; Mantovani R; Howard PW; Morris P; Thurston DE; Hartley JA; Hochhauser D
Mol Cancer Ther; 2008 May; 7(5):1319-28. PubMed ID: 18483319
[TBL] [Abstract][Full Text] [Related]
33. Hypophosphorylation of topoisomerase IIalpha in etoposide (VP-16)-resistant human carcinoma cell lines associated with carboxy-terminal truncation.
Matsumoto Y; Takano H; Kunishio K; Nagao S; Fojo T
Jpn J Cancer Res; 2001 Jul; 92(7):799-805. PubMed ID: 11473732
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a potential regulatory role for inverted CCAAT boxes in the human topoisomerase II alpha promoter.
Herzog CE; Zwelling LA
Biochem Biophys Res Commun; 1997 Mar; 232(3):608-12. PubMed ID: 9126321
[TBL] [Abstract][Full Text] [Related]
35. A novel point mutation in the 3' flanking region of the DNA-binding domain of topoisomerase II alpha associated with acquired resistance to topoisomerase II active agents.
Hashimoto S; Danks MK; Chatterjee S; Beck WT; Berger NA
Oncol Res; 1995; 7(1):21-9. PubMed ID: 7549041
[TBL] [Abstract][Full Text] [Related]
36. Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide.
Asano T; An T; Zwelling LA; Takano H; Fojo AT; Kleinerman ES
Oncol Res; 1996; 8(3):101-10. PubMed ID: 8823806
[TBL] [Abstract][Full Text] [Related]
37. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
[TBL] [Abstract][Full Text] [Related]
38. Topoisomerase II is required for mitoxantrone to signal nuclear factor kappa B activation in HL60 cells.
Boland MP; Fitzgerald KA; O'Neill LA
J Biol Chem; 2000 Aug; 275(33):25231-8. PubMed ID: 10940316
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of DNA topoisomerase IIalpha in human colorectal carcinoma cells resistant to a protoberberine alkaloid, berberrubine.
Kang MR; Chung IK
Mol Pharmacol; 2002 Apr; 61(4):879-84. PubMed ID: 11901227
[TBL] [Abstract][Full Text] [Related]
40. p53 modulation of DNA topoisomerase IIalpha gene expression.
Joshi AA; Wang Q; Suttle DP
Cell Biochem Biophys; 2000; 33(2):209-16. PubMed ID: 11325041
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]